Bausch Health
BHC
327 hedge funds and large institutions have $6.71B invested in Bausch Health in 2019 Q4 according to their latest regulatory filings, with 73 funds opening new positions, 85 increasing their positions, 120 reducing their positions, and 52 closing their positions.
49% more capital invested
Capital invested by funds: $4.5B → $6.71B (+$2.21B)
46% more funds holding in top 10
Funds holding in top 10: 13 → 19 (+6)
40% more first-time investments, than exits
New positions opened: 73 | Existing positions closed: 52
4.81% more ownership
Funds ownership: 58.56% → 63.36% (+4.8%)
4% more funds holding
Funds holding: 315 → 327 (+12)
2% less call options, than puts
Call options by funds: $491M | Put options by funds: $502M
29% less repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 120
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$193M |
| 2 |
SPC
Slate Path Capital
New York
|
+$145M |
| 3 |
EIP
Epoch Investment Partners
New York
|
+$124M |
| 4 |
GCM
Glenview Capital Management
New York
|
+$73M |
| 5 |
Morgan Stanley
New York
|
+$68.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$129M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$48.1M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$36.7M |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$32.5M |
| 5 |
CC
Cannell & Co
New York
|
-$29.3M |
BHC Hedge Fund Activity: Q4 2019 in Review
327 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q4 2019, worth a combined $6.71B — up 49% from $4.5B a quarter earlier.
Buyers outnumbered sellers: 73 funds opened new BHC positions and 52 closed out — a net gain of 21 holders — while 85 added to existing stakes and 120 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $193M. The largest seller was Susquehanna International Group, cutting an estimated $129M.
- 327 institutional investors held Bausch Health (BHC) as of Q4 2019, up from 315 in Q3 2019.
- Funds reported $6.71B of Bausch Health stock for Q4 2019, up 49% quarter-over-quarter.
- 73 funds opened new Bausch Health positions in Q4 2019 and 52 closed out, a net change of +21 holders.
- The largest Bausch Health buyer in Q4 2019 was Renaissance Technologies, an estimated $193M added.
- The largest Bausch Health seller in Q4 2019 was Susquehanna International Group, an estimated $129M sold.
Based on aggregated 13F filings for Q4 2019.